[go: up one dir, main page]

SV2003001439A - Metodos y composiciones para el tratamiento de patologias respiratorias - Google Patents

Metodos y composiciones para el tratamiento de patologias respiratorias

Info

Publication number
SV2003001439A
SV2003001439A SV2002001439A SV2002001439A SV2003001439A SV 2003001439 A SV2003001439 A SV 2003001439A SV 2002001439 A SV2002001439 A SV 2002001439A SV 2002001439 A SV2002001439 A SV 2002001439A SV 2003001439 A SV2003001439 A SV 2003001439A
Authority
SV
El Salvador
Prior art keywords
compositions
methods
treatment
pathologies
respiratory pathologies
Prior art date
Application number
SV2002001439A
Other languages
English (en)
Inventor
Lionel Bueno
Original Assignee
Rytek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0116706A external-priority patent/FR2833839A1/fr
Application filed by Rytek filed Critical Rytek
Publication of SV2003001439A publication Critical patent/SV2003001439A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE SOLICITUD SE REFIERE A COMPOSICIONES Y METODOS PARA TRATAR PATOLOGIAS RESPIRATORIAS. TAMBIEN SE REFIERE A COMPOSICIONES Y METODOS QUE PERMITEN LA REGULACION DE LA PERMEABILIDAD PARACELULAR DEL EPITELIO PULMONAR. LAS COMPOSICIONES Y LOS METODOS DE LA INVENCION SE BASAN, EN PARTICULAR, EN EL USO DE AGENTES O CONDICIONES QUE MODULAN LA TENSION DEL CITOESQUELETO DE LAS CELULAS EPITELIALES PULMONARES, EN PARTICULAR, LOS ENTEROCITOS. LA INVENCION PUEDE USARSE PARA EL TRATAMIENTO PREVENTIVO O CURATIVO DE VARIAS PATOLOGIAS, COMO EL ASMA, LAS ALERGIAS, LAS ENFERMEDADES OBSTRUCTIVAS, ETC. EN MAMIFEROS, PARTICULARMENTE EN SERES HUMANOS.
SV2002001439A 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologias respiratorias SV2003001439A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116706A FR2833839A1 (fr) 2001-12-21 2001-12-21 Methodes et compositions pour le traitement de pathologies respiratoires
FR0208606A FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires

Publications (1)

Publication Number Publication Date
SV2003001439A true SV2003001439A (es) 2003-11-04

Family

ID=26213306

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002001439A SV2003001439A (es) 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologias respiratorias

Country Status (12)

Country Link
US (2) US20050019314A1 (es)
EP (1) EP1455767A2 (es)
AR (1) AR038042A1 (es)
AU (1) AU2002364679A1 (es)
CA (1) CA2470442A1 (es)
FR (1) FR2833840B1 (es)
PA (1) PA8562701A1 (es)
PE (1) PE20030853A1 (es)
SV (1) SV2003001439A (es)
TW (1) TW200305447A (es)
UY (1) UY27589A1 (es)
WO (1) WO2003053422A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
MY144231A (en) * 2003-12-17 2011-08-15 Wyeth Corp Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
CA2576971A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
FR2879100B1 (fr) * 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
US7893050B2 (en) * 2005-10-26 2011-02-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US20100144646A1 (en) * 2006-11-03 2010-06-10 Blake Paterson Method of diagnosing and treating asthma
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose
FR3145744A1 (fr) 2023-02-11 2024-08-16 Marc Grosman Drone comportant au moins une pile à combustible, un calculateur dont un élément quantique ou supraconducteur, capable de réaliser plusieurs tâches au cours d’un vol sur zone difficile d’accès.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748A (en) * 1844-09-17 Improvement in ratoon and cane cutters
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
FR2674434B1 (fr) * 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
US5336503A (en) * 1992-03-31 1994-08-09 Daiichi Pharmaceutical Co., Ltd. Anti-peptic ulcer agent
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
WO1994019336A1 (fr) * 1993-02-19 1994-09-01 Asahi Kasei Kogyo Kabushiki Kaisha Derive de benzothiazolesulfonamide, procede de production et application de ce derive
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
SI0956865T2 (sl) * 1996-08-12 2011-04-29 Mitsubishi Pharma Corp Zdravila, ki obsegajo inhibitor Rho-kinaze
AU9495798A (en) * 1997-09-19 1999-04-05 Ludwig Institute For Cancer Research Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU4990599A (en) * 1998-07-14 2000-02-07 Brigham And Women's Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
MXPA03001468A (es) * 2000-08-15 2004-05-04 Immunex Corp Polipeptidos de claudia.

Also Published As

Publication number Publication date
TW200305447A (en) 2003-11-01
AR038042A1 (es) 2004-12-22
US20030125321A1 (en) 2003-07-03
US20050019314A1 (en) 2005-01-27
AU2002364679A1 (en) 2003-07-09
UY27589A1 (es) 2003-05-30
EP1455767A2 (fr) 2004-09-15
CA2470442A1 (fr) 2003-07-03
PE20030853A1 (es) 2003-10-28
PA8562701A1 (es) 2004-02-16
WO2003053422A2 (fr) 2003-07-03
FR2833840A1 (fr) 2003-06-27
FR2833840B1 (fr) 2010-06-18
AU2002364679A8 (en) 2003-07-09
WO2003053422A3 (fr) 2004-04-15

Similar Documents

Publication Publication Date Title
IL181740A0 (en) THERAPEUTIC AGENTS TARGETING THE NCca-atp CHANNEL AND METHODS OF USE THEREOF
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
CY1113094T1 (el) Ανοσοσφαιρινες κατευθυνομενες εναντι nogo
IS9028A (is) Ný efnablanda
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
IL181826A0 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
PT1881823E (pt) Composições e métodos para o tratamento de transtornos oculares
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
DOP2007000015A (es) Usos terapéuticos de inhibidores de rtp801
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
WO2003072593A3 (en) Bone targeting peptides
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
BR0117009A (pt) Composiçoes para utilização no tratamento de distúrbios associados a ige
CY1111285T1 (el) Θεραπεια αυτοανοσων ασθενειων
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades
SV2003001439A (es) Metodos y composiciones para el tratamiento de patologias respiratorias
HN2003000080A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
DK1988909T3 (da) Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
UY29417A1 (es) Agentes endoparasiticidas
GT199900167A (es) Nuevos bis-benzimidazoles.
HN2002000374A (es) Metodos y composiciones para el tratamiento de patologias respiratorias

Legal Events

Date Code Title Description
FG Grant
FD Lapse